story of the week
Effects of Semaglutide With and Without Concomitant SGLT2 Inhibitor Use in People With Type 2 Diabetes and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
Nat. Med. 2024 Jun 24;[EPub Ahead of Print], JFE Mann, P Rossing, G Bakris, N Belmar, H Bosch-Traberg, R Busch, DM Charytan, S Hadjadj, P Gillard, JL Górriz, T Idorn, L Ji, KW Mahaffey, V Perkovic, S Rasmussen, RE Schmieder, RE Pratley, KR TuttleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.